SCHEMBL4931363

SCHEMBL4931363

O=C(NCc1ccc(C(=O)NO)cc1)NC(=O)c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.79
HDAC6 Q9UBN7 14/20 0.77
HDAC1 Q13547 12/20 0.77
HDAC8 Q9BY41 9/20 0.69
HDAC2 Q92769 8/20 0.69
HDAC11 Q96DB2 6/20 0.66
HDAC3 O15379 6/20 0.66
HDAC7 Q8WUI4 6/20 0.66
HDAC4 P56524 5/20 0.66
HDAC10 Q969S8 5/20 0.66
HDAC9 Q9UKV0 5/20 0.66
HDAC5 Q9UQL6 5/20 0.66
MITF O75030 1/20 0.56
ALDH1A1 P00352 1/20 0.56
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
IDO1 P14902 1/20 0.56
ALOX15 P16050 1/20 0.56
CA9 Q16790 1/20 0.56
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919516 0.89 HDAC6 (0.81) TP53HDAC6HDAC1HDAC8HDAC2
SCHEMBL5013790 0.89 TP53 (1.00) TP53HDAC6HDAC1HDAC8HDAC2
SCHEMBL2829167 0.87 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC2HDAC11
SCHEMBL14260700 0.86 HDAC1 (0.80) TP53HDAC6HDAC1HDAC8HDAC2
SCHEMBL4931020 0.84 TP53 (0.72) TP53HDAC6HDAC1HDAC11HDAC3
SCHEMBL8292059 0.83 TP53 (0.67) TP53HDAC6HDAC1HDAC8HDAC2
SCHEMBL6570908 0.82 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC2HDAC11
SCHEMBL14260699 0.81 HDAC6 (0.58) TP53HDAC6HDAC1HDAC8HDAC2
SCHEMBL8291939 0.81 TP53 (0.68) TP53HDAC6HDAC1HDAC2HDAC3
SCHEMBL28024624 0.81 HDAC6 (0.77) HDAC6HDAC1HDAC8HDAC2HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US claimed
EP-1685094-A4 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S BIO PTE LTD (SG) 2007-08-22 EP claimed
EP-1685094-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*Bio Pte Ltd (SG) 2006-08-02 EP claimed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO claimed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed
EP-1685094-A4 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S BIO PTE LTD (SG) 2007-08-22 EP disclosed
EP-1685094-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*Bio Pte Ltd (SG) 2006-08-02 EP disclosed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO disclosed
WO-2005040101-A1 ACYLUREA CONNECTED AND SULFONYLUREA CONNECTED HYDROXAMATES S*BIO PTE LTD (SG) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 TP53 3230/4885HDAC6 11/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.